Literature DB >> 26036858

High acceptance of an early dyslexia screening test involving genetic analyses in Germany.

Arndt Wilcke1,2, Bent Müller1, Gesa Schaadt3,4, Holger Kirsten1,2,5,6, Johannes Boltze1,2,7.   

Abstract

Dyslexia is a developmental disorder characterized by severe problems in the acquisition of reading and writing skills. It has a strong neurobiological basis. Genetic influence is estimated at 50-70%. One of the central problems with dyslexia is its late diagnosis, normally not before the end of the 2nd grade, resulting in the loss of several years for early therapy. Currently, research is focusing on the development of early tests for dyslexia, which may be based on EEG and genetics. Our aim was to determine the acceptance of such a future test among parents. We conducted a representative survey in Germany with 1000 parents of children aged 3-7 years, with and without experience of dyslexia. 88.7% of the parents supported the introduction of an early test for dyslexia based on EEG and genetics; 82.8% would have their own children tested, and 57.9% were willing to pay for the test if health insurance did not cover the costs. Test acceptance was significantly higher if parents had prior experience with dyslexia. The perceived benefits of such a test were early recognition and remediation and, preventing deficits. Concerns regarded the precision of the test, its potentially stigmatizing effect and its costs. The high overall support for the test leads to the conclusion that parents would accept a test for dyslexia based on EEG and genetics.

Entities:  

Mesh:

Year:  2015        PMID: 26036858      PMCID: PMC4717194          DOI: 10.1038/ejhg.2015.103

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.

Authors:  Joan L Bottorff; Pamela A Ratner; Lynda G Balneaves; Chris G Richardson; Mary McCullum; Tom Hack; Karen Chalmers; Jane Buxton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

2.  The impact of orthographic consistency on dyslexia: a German-English comparison.

Authors:  K Landerl; H Wimmer; U Frith
Journal:  Cognition       Date:  1997-06

3.  Development of the Grammar and Phonology Screening (GAPS) test to assess key markers of specific language and literacy difficulties in young children.

Authors:  Hilary Gardner; Karen Froud; Alastair McClelland; Heather K J van der Lely
Journal:  Int J Lang Commun Disord       Date:  2006 Sep-Oct       Impact factor: 3.020

Review 4.  The mismatch negativity in evaluating central auditory dysfunction in dyslexia.

Authors:  T Kujala; R Näätänen
Journal:  Neurosci Biobehav Rev       Date:  2001-08       Impact factor: 8.989

Review 5.  [Genetics of dyslexia].

Authors:  Gerd Schulte-Körne; Andreas Warnke; Helmut Remschmidt
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2006-11

6.  Attitude and knowledge about genetics and genetic testing.

Authors:  H Etchegary; M Cappelli; B Potter; M Vloet; I Graham; M Walker; B Wilson
Journal:  Public Health Genomics       Date:  2009-05-19       Impact factor: 2.000

7.  Attitudes about genetic testing for breast-ovarian cancer susceptibility.

Authors:  C Lerman; M Daly; A Masny; A Balshem
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

8.  Cross-national comparisons of developmental dyslexia in Italy and the United States.

Authors:  S D Lindgren; E De Renzi; L C Richman
Journal:  Child Dev       Date:  1985-12

9.  Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.

Authors:  M Bruno; M Digennaro; S Tommasi; B Stea; T Danese; F Schittulli; A Paradiso
Journal:  Eur J Cancer Care (Engl)       Date:  2009-11-13       Impact factor: 2.520

Review 10.  Using the Internet for surveys and health research.

Authors:  Gunther Eysenbach; Jeremy Wyatt
Journal:  J Med Internet Res       Date:  2002 Apr-Nov       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.